Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. CDC Says Delivered 329,840,055 Doses Of Covid-19 Vaccine As Of May 8 Versus 327,124,625 Doses As Of May 7

05/08/2021 | 02:15pm EDT

May 8 (Reuters) -

* U.S. CDC SAYS DELIVERED 329,840,055 DOSES OF COVID-19 VACCINE AS OF MAY 8 VERSUS 327,124,625 DOSES AS OF MAY 7

* U.S. CDC SAYS ADMINISTERED 257,347,205 DOSES OF COVID-19 VACCINE AS OF MAY 8 VERSUS 254,779,333 DOSES AS OF MAY 7

* U.S. CDC SAYS 151,315,505 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF MAY 8 VERSUS 150,416,559 INDIVIDUALS AS OF MAY 7

* U.S. CDC SAYS 112,626,771 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF MAY 8 VERSUS 110,874,920 INDIVIDUALS AS OF MAY 7

* U.S. CDC SAYS 7,811,741 DOSES OF COVID-19 VACCINE ADMINISTERED IN LONG-TERM CARE HOMES AS OF MAY 8 VERSUS 7,808,441 DOSES ADMINISTERED AS OF MAY 7 Source text: https://bit.ly/3xX4bSA


© Reuters 2021
All news about MODERNA, INC.
05:22pMODERNA  : Canadian co-founder of Moderna wins science award for mRNA research
AQ
04:54pUS Stocks End Mixed, Nasdaq Hits Intraday High on Tesla Rally
MT
04:45pCLOSE UPDATE : US Stocks End Mixed, Nasdaq Hits Intraday High on Tesla Rally
MT
04:22pTHE LATEST : Israel delays reopening of borders to tourists
AQ
03:51pMODERNA  : U.S. CDC Says Administered 319,872,053 Doses Of Covid-19 Vaccine As O..
RE
03:12pMODERNA  : NIH begins clinical trial testing COVID-19 vaccine in pregnant women
RE
01:19pStocks Mixed Midday as Defensives Trade Lower; Oil Advances as Crude Stockpil..
MT
01:04pMIDDAY REPORT : US Stocks Mixed as Defensives Trade Lower; Oil Advances as Crude..
MT
12:02pMODERNA  : 'Likely link' between rare heart inflammation and Pfizer, Moderna vac..
RE
11:49aUS' CDC To Study Possible Link Between Heart Inflammation And Pfizer/BioNTech..
MT
More news
Financials (USD)
Sales 2021 18 632 M - -
Net income 2021 10 719 M - -
Net cash 2021 11 520 M - -
P/E ratio 2021 8,60x
Yield 2021 -
Capitalization 85 140 M 85 140 M -
EV / Sales 2021 3,95x
EV / Sales 2022 4,04x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 212,04 $
Average target price 168,87 $
Spread / Average Target -20,4%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.102.97%88 882
LONZA GROUP AG14.06%52 367
IQVIA HOLDINGS INC.36.17%46 761
CELLTRION, INC.-21.59%32 903
SEAGEN INC.-9.40%28 797
HANGZHOU TIGERMED CONSULTING CO., LTD20.45%25 469